1. Home
  2. CFND vs FORA Comparison

CFND vs FORA Comparison

Compare CFND & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CFND

C1 Fund Inc.

N/A

Current Price

$3.82

Market Cap

27.4M

Sector

N/A

ML Signal

N/A

Logo Forian Inc.

FORA

Forian Inc.

N/A

Current Price

$2.08

Market Cap

66.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CFND
FORA
Founded
N/A
2014
Country
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.4M
66.2M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
CFND
FORA
Price
$3.82
$2.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.8K
16.6K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$20,153,263.00
Revenue This Year
N/A
$51.82
Revenue Next Year
N/A
$7.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.68
$1.64
52 Week High
$9.67
$2.71

Technical Indicators

Market Signals
Indicator
CFND
FORA
Relative Strength Index (RSI) 44.45 46.06
Support Level $3.82 $2.05
Resistance Level $4.08 $2.12
Average True Range (ATR) 0.16 0.02
MACD 0.03 0.00
Stochastic Oscillator 70.00 40.00

Price Performance

Historical Comparison
CFND
FORA

About CFND C1 Fund Inc.

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: